252 related articles for article (PubMed ID: 34439277)
1. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance.
Lawal B; Tseng SH; Olugbodi JO; Iamsaard S; Ilesanmi OB; Mahmoud MH; Ahmed SH; Batiha GE; Wu ATH
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439277
[TBL] [Abstract][Full Text] [Related]
2. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer.
Bao D; Zhang C; Li L; Wang H; Li Q; Ni L; Lin Y; Huang R; Yang Z; Zhang Y; Hu Y
Front Oncol; 2020; 10():553297. PubMed ID: 33614473
[TBL] [Abstract][Full Text] [Related]
3. Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4
Hansen CB; Willer A; Bayarri-Olmos R; Kemper C; Garred P
Immunobiology; 2019 Mar; 224(2):307-315. PubMed ID: 30612786
[TBL] [Abstract][Full Text] [Related]
4. Follicular B2 Cell Activation and Class Switch Recombination Depend on Autocrine C3ar1/C5ar1 Signaling in B2 Cells.
Paiano J; Harland M; Strainic MG; Nedrud J; Hussain W; Medof ME
J Immunol; 2019 Jul; 203(2):379-388. PubMed ID: 31217324
[TBL] [Abstract][Full Text] [Related]
5. Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability.
Medof ME; Rieder SA; Shevach EM
J Immunol; 2023 Nov; 211(9):1359-1366. PubMed ID: 37756526
[TBL] [Abstract][Full Text] [Related]
6. Effect of avian influenza virus subtype H9N2 on the expression of complement-associated genes in chicken erythrocytes.
Zhou J; Qiao ML; Jahejo AR; Han XY; Wang P; Wang Y; Ren JL; Niu S; Zhao YJ; Zhang D; Bi YH; Wang QH; Si LL; Fan RW; Shang GJ; Tian WX
Br Poult Sci; 2023 Aug; 64(4):467-475. PubMed ID: 36939295
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
Front Immunol; 2022; 13():942493. PubMed ID: 36466856
[TBL] [Abstract][Full Text] [Related]
8. Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement.
Keragala CB; Woodruff TM; Liu Z; Niego B; Ho H; McQuilten Z; Medcalf RL
Front Neurol; 2020; 11():577272. PubMed ID: 33363504
[No Abstract] [Full Text] [Related]
9. C5aR1 is a master regulator in Colorectal Tumorigenesis via Immune modulation.
Ding P; Li L; Li L; Lv X; Zhou D; Wang Q; Chen J; Yang C; Xu E; Dai W; Zhang X; Wang N; Wang Q; Zhang W; Zhang L; Zhou Y; Gu H; Lei Q; Zhou X; Hu W
Theranostics; 2020; 10(19):8619-8632. PubMed ID: 32754267
[TBL] [Abstract][Full Text] [Related]
10. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types.
Wu SY; Lin KC; Lawal B; Wu ATH; Wu CZ
Comput Struct Biotechnol J; 2021; 19():4970-4983. PubMed ID: 34584637
[TBL] [Abstract][Full Text] [Related]
11. C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer.
Zhang C; Cao K; Yang M; Wang Y; He M; Lu J; Huang Y; Zhang G; Liu H
Oncoimmunology; 2023; 12(1):2261242. PubMed ID: 37791232
[TBL] [Abstract][Full Text] [Related]
12. Molecular signatures of intrarenal complement receptors
Tampe D; Hakroush S; Tampe B
Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36521939
[TBL] [Abstract][Full Text] [Related]
13. Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment.
Huang J; Zhou L; Deng K
J Ovarian Res; 2023 Apr; 16(1):64. PubMed ID: 37005667
[TBL] [Abstract][Full Text] [Related]
14. High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels.
Yang H; Li L; Liu X; Zhao Y
Med Sci Monit; 2021 Feb; 27():e927977. PubMed ID: 33539329
[TBL] [Abstract][Full Text] [Related]
15. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma.
Hasegawa K; Tamari M; Shao C; Shimizu M; Takahashi N; Mao XQ; Yamasaki A; Kamada F; Doi S; Fujiwara H; Miyatake A; Fujita K; Tamura G; Matsubara Y; Shirakawa T; Suzuki Y
Hum Genet; 2004 Sep; 115(4):295-301. PubMed ID: 15278436
[TBL] [Abstract][Full Text] [Related]
16. C5aR1 shapes a non-inflammatory tumor microenvironment and mediates immune evasion in gastric cancer.
Shen H; Gu X; Li X; Xiang Z; Zhang R; Shi F; Tang M; Li H; Zhu G; Su F; Wang Z
Biomol Biomed; 2023 May; 23(3):392-404. PubMed ID: 36508191
[TBL] [Abstract][Full Text] [Related]
17. Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research - 20 years of experience and future perspectives.
Mollnes TE; Storm BS; Brekke OL; Nilsson PH; Lambris JD
Semin Immunol; 2022 Jan; 59():101604. PubMed ID: 35570131
[TBL] [Abstract][Full Text] [Related]
18. Complement C3a receptor inactivation attenuates retinal degeneration induced by oxidative damage.
Wang S; Du L; Yuan S; Peng GH
Front Neurosci; 2022; 16():951491. PubMed ID: 36110094
[TBL] [Abstract][Full Text] [Related]
19. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
[TBL] [Abstract][Full Text] [Related]
20. VEGFR2 survival and mitotic signaling depends on joint activation of associated C3ar1/C5ar1 and IL-6R-gp130.
Hwang MS; Strainic MG; Pohlmann E; Kim H; Pluskota E; Ramirez-Bergeron DL; Plow EF; Medof ME
J Cell Sci; 2019 Mar; 132(6):. PubMed ID: 30765465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
